Wynn et al: “Synthesis and bioevaluation of a series of fatty acid esters of p-(n,n-Bis(2-chloroethyl)amino)phenol” Journal of Pharmaceutical Sciences, vol. 71, No. 7, Jul. 1982, pp. 772-776, XP002105522. |
Sykes et al: “Kinetics and mechanism of the cyclization of substituted n-phenyl-2-methyl-2-(2-aminophenyl) propana mides and analogues” Journal of the Chemical Society, Perkins Transactions 2, 1995, pp. 337-342, XP002105523. |
Carpino et al: “Reductive Tactonization of strategically methylated quinnone propionic acid esters and amides”, Journal of Organic Chemistry, vol. 54, No. 14, Jul. 7, 1989, pp. 3303-3310, XP002105524. |
Chikhale et al: “Tumor targeted Prodrugs: Redox-Activation of Conformationally Constrained, Bioreductive Melphalan Prodrugs”, Proceedings of the 88th, Annual Meeting of the American Association for Cancer Research, Apr. 12-16, 1997, vol. 38, Apr. 12, 1997, p. 432, XP002052354. |
Atwell et al., “Relationships between Structure and Kinetics of Cyclization of 2-Aminoaryl Amides: Potential Prodrugs of Cyclization-Activated Aromatic Mustards”, J. Med. Chem. 1994, vol. 37, pp. 371-380. |
Ross et al., “Arly-2-halogenoalkylamines. Part XIV. * Some Compounds posessing latent Cytotojxic Activity;” Journal of the Chemical Society, 1995, pp. 3110-3116, XP002105519. |
Sasiela et al., “Bioreductively-activated antitumor drug delivery systems designed to optimize solid tumor targeting and avoid neurotoxicity.” Pharmacology and Experimental Therapeutics, Proceedings of the American Association for Cancer Rsearch, Mar. 1998, vol. 39, pp. 426. |